X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Merck to Pay $270M for Rights to Insomnia Treatment Drug Merck & Co. of Whitehouse Station announced last Tuesday it would pay $270 million to H. Lundbeck A/S of Denmark, a pharmaceutical company, for the U.S. rights to its gaboxadol insomnia treatment. Hoffmann-La Roche to Sell Drug Rights to Connetics Connetics Corp. of Palo Alto, Calif., a dermatology drug maker, agreed last Monday to pay $123 million for the U.S. rights to Soriatane, a psoriasis treatment, from Hoffmann-La Roche Inc. of Nutley, the U.S. prescription drug unit of the Roche Group of Switzerland. Wyeth Sells SPL for $81M Pharmaceutical maker Wyeth, of Madison, announced last Wednesday the $81 million sale of Scientific Protein Laboratories, a maker of pharmaceutical ingredients in Waunakee, Wis., to Arsenal Capital Partners L.P. of New York City, a private equity firm. Creative Beauty Supply to Merge With Global Digital Solutions Inc. Creative Beauty Supply Inc. of Totowa, a cosmetics and beauty supply distributor, agreed on Feb. 4 to merge with Global Digital Solutions Inc. of West Palm Beach, Fla., a communications company, in a $12 million reverse stock swap. The combined company will be called GDSI. Compiled by Amy E. Rice from Thomson Financial/Securities Data and other sources

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.